M&A/IPOs

 

Lack of debt may hit M&A in second half

M&A deals in health care services such as the bid for British health and beauty retailer and pharmacy chain Boots are coming under threat as market uncertainty, interest rates and inflation soar. Massive deals may fail if debt dries up. This could lead to a further slow-down in M&A activity in the second half of 2022, following a record year 2021.

Metropolis denies it is open to bidders

Metropolis Healthcare, the big Indian diagnostic and pathology group, is determined to forestall potential predators despite talk of a $1bn joint bid from hospital chain Apollo and conglomerate Adani Group.

Largest lab group in GCC likely to list

Al Borg Diagnostics with 64 labs across 8 countries in GCC and Africa and a dominant position in Saudi Arabia, its home market, looks set to finally list in 2022. We speculate (wildly!) on valuation.

KKR mulls post-takeover Ramsay sale-and-leaseback deal

The consortium led by private equity firm KKR is reportedly planning sale-and-leaseback deals should its proposed US$15bn takeover of multinational hospital group Ramsay Health Care prove successful, and is looking for suitors.

Mediclinic rejects £3.4bn takeover bid from consortium led by largest shareholder

Multinational South African hospital group Mediclinic has rejected a proposal for a possible cash offer of £3.4bn for the company’s entire share capital. The proposal came from a consortium comprising Mediclinic’s current largest shareholder, South African investment holding firm Remgro, and Mediterranean Shipping Company (MSC), the world’s second largest container shipping provider.

IDH sells DD Group

The owner of UK-based dental specialist IDH, Palamon Capital, is selling DD Group (formerly Dental Directory), its UK and Ireland-based dental and medical aesthetics distributer and service provider. Palamon says this concludes phase one of its investment plan to return IDH to a pure-play dental service.

Find Us